Detalhe da pesquisa
1.
Safety and efficacy of a humanized CD19 chimeric antigen receptor T cells for relapsed/refractory acute lymphoblastic leukemia.
Am J Hematol
; 97(6): 711-718, 2022 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35179242
2.
Predicting early post-chemotherapy adverse events in patients with hematological malignancies: a retrospective study.
Support Care Cancer
; 24(6): 2727-33, 2016 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-26803835
3.
Autoimmune hemolytic anemia and thrombocytopenia in a Chinese patient with heterozygous NBAS mutations: Case report.
Medicine (Baltimore)
; 103(12): e36975, 2024 Mar 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-38517998
4.
Dysregulated CXCL12 expression in osteoblasts promotes B-lymphocytes preferentially homing to the bone marrow in MRL/lpr mice.
Autoimmunity
; 57(1): 2319207, 2024 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-38404066
5.
[Risk Factors and the Effect of Antiviral Prophylaxis for Herpes Zoster in Multiple Myeloma Patients].
Zhongguo Shi Yan Xue Ye Xue Za Zhi
; 32(1): 171-175, 2024 Feb.
Artigo
em Chinês
| MEDLINE | ID: mdl-38387917
6.
Bispecific CAR T cell therapy targeting BCMA and CD19 in relapsed/refractory multiple myeloma: a phase I/II trial.
Nat Commun
; 15(1): 3371, 2024 Apr 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38643278
7.
Case report: Deep molecular remissions post two separate CD19-targeted chimeric antigen receptor T-cell therapies do not prevent disease from relapsing in Philadelphia chromosome-positive acute lymphoblastic leukemia.
Front Oncol
; 13: 1251738, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-38023231
8.
Long-term analysis of cellular immunity in patients with RRMM treated with CAR-T cell therapy.
Clin Exp Med
; 23(8): 5241-5254, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37907623
9.
[Analysis of Related Factors of Autologous Peripheral Hematopoietic Stem Cell Mobilization in Patients with Lymphoma and Myeloma].
Zhongguo Shi Yan Xue Ye Xue Za Zhi
; 30(6): 1861-1867, 2022 Dec.
Artigo
em Chinês
| MEDLINE | ID: mdl-36476917
10.
[Effect of Doxycycline on Intrinsic Apoptosis of Myeloma Cell Line H929 and Its Mechanism].
Zhongguo Shi Yan Xue Ye Xue Za Zhi
; 30(2): 441-448, 2022 Apr.
Artigo
em Chinês
| MEDLINE | ID: mdl-35395977
11.
[The Effect of Doxycycline on the Expression of MMP-2 and MMP-9 in Multiple Myeloma].
Zhongguo Shi Yan Xue Ye Xue Za Zhi
; 30(2): 487-492, 2022 Apr.
Artigo
em Chinês
| MEDLINE | ID: mdl-35395984
12.
Long-Term Follow-Up of Combination of B-Cell Maturation Antigen and CD19 Chimeric Antigen Receptor T Cells in Multiple Myeloma.
J Clin Oncol
; 40(20): 2246-2256, 2022 07 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35333600
13.
Bilateral anterior cerebral artery occlusion following CD19- and BCMA-targeted chimeric antigen receptor T-cell therapy for a myeloma patient.
Int J Hematol
; 114(3): 408-412, 2021 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-34009622
14.
[Up-Regulation of PI3K/Akt Signaling Pathway in H929 Cell Line by Doxycycline Not Beneficial to Its Anti-Myeloma Effect].
Zhongguo Shi Yan Xue Ye Xue Za Zhi
; 28(5): 1605-1610, 2020 Oct.
Artigo
em Chinês
| MEDLINE | ID: mdl-33067961
15.
[Increment of N-cadherin Expression in Bone Marrow Mesenchymal Stem Cells Accompanies by Imparment of Bone Marrow B Lymphocyte Production in MRL/lpr Lupus Mice].
Zhongguo Shi Yan Xue Ye Xue Za Zhi
; 27(3): 964-969, 2019 Jun.
Artigo
em Chinês
| MEDLINE | ID: mdl-31204962
16.
A combination of humanised anti-CD19 and anti-BCMA CAR T cells in patients with relapsed or refractory multiple myeloma: a single-arm, phase 2 trial.
Lancet Haematol
; 6(10): e521-e529, 2019 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-31378662
17.
[IL-1ß-Treated Bone Marrow Mesenchymal Stem Cells Enhances Osteogenetic Potential via NF-κB Pathway].
Zhongguo Shi Yan Xue Ye Xue Za Zhi
; 25(3): 890-895, 2017 Jun.
Artigo
em Chinês
| MEDLINE | ID: mdl-28641655
18.
[Clinical Efficacy of Decitabine Combined with Modified CAG Regimen for Relapse/Refractory Acute Myeloid Leukemia with AML1-ETO].
Zhongguo Shi Yan Xue Ye Xue Za Zhi
; 24(5): 1334-1338, 2016 Oct.
Artigo
em Chinês
| MEDLINE | ID: mdl-27784352
19.
Clinicopathologic analysis of POEMS syndrome and related diseases.
Clin Lymphoma Myeloma Leuk
; 15(1): e15-21, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25131854
20.
In vitro migratory aberrancies of mesenchymal stem cells derived from multiple myeloma patients only partially modulated by bortezomib.
Int J Clin Exp Pathol
; 7(10): 6705-15, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-25400750